Clinical Trial Update: Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam [Phase 3]

View source ↗

Summary

Phase 3 study evaluating a MenACYW quadrivalent meningococcal conjugate vaccine administered as a single dose to participants aged 12 months and older in Vietna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infection

Drugs mentioned

• MenACYW Conjugate Vaccine (MenACWY conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Infection, Healthy Volunteers | Phase 3 | Status: COMPLETED | Results posted: 2025-09-17